テトラヒドロゲストリノン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "テトラヒドロゲストリノン" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

2endojournals.org

low place

low place

28^th place

188^th place

447^th place

1,043^rd place

1endocrinology-journals.org

low place

low place

610^th place

915^th place

8^th place

73^rd place

41^st place

199^th place

1chicagotribune.com

95^th place

769^th place

bbc.co.uk

news.bbc.co.uk

“Jones pleads guilty in drug case”. BBC News. (2007年10月6日) 2010年5月25日閲覧。

chicagotribune.com

articles.chicagotribune.com

Hersh, Philip (2003年12月26日). “Success in a troubled year”. シカゴ・トリビューン. 2011年8月18日閲覧。

cnn.com

vault.sportsillustrated.cnn.com

“Is This Dr. Evil?”. CNN. (2006年10月9日) 2011年8月18日閲覧。

doi.org

Death AK, McGrath KC, Kazlauskas R, Handelsman DJ (May 2004), “Tetrahydrogestrinone is a potent androgen and progestin”, J. Clin. Endocrinol. Metab. 89 (5): 2498-500, doi:10.1210/jc.2004-0033, PMID 15126583
Labrie F, Luu-The V, Calvo E, et al. (February 2005), “Tetrahydrogestrinone induces a genomic signature typical of a potent anabolic steroid”, J. Endocrinol. 184 (2): 427-33, doi:10.1677/joe.1.05997, PMID 15684350
Jasuja R, Catlin DH, Miller A, et al. (October 2005), “Tetrahydrogestrinone is an androgenic steroid that stimulates androgen receptor-mediated, myogenic differentiation in C3H10T1/2 multipotent mesenchymal cells and promotes muscle accretion in orchidectomized male rats”, Endocrinology 146 (10): 4472-8, doi:10.1210/en.2005-0448, PMID 15976054
Kicman AT (June 2008), “Pharmacology of anabolic steroids”, Br. J. Pharmacol. 154 (3): 502-21, doi:10.1038/bjp.2008.165, PMC 2439524, PMID 18500378
Thevis M, Schanzer W (2005), “Mass Spectrometry in Doping Control Analysis”, Current Organic Chemistry 9: 825-848, doi:10.2174/1385272054038318
Friedel A, Geyer H, Kamber M, et al. (June 2006), “Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucocorticoid signalling in the liver”, Toxicol. Lett. 164 (1): 16-23, doi:10.1016/j.toxlet.2005.11.006, PMID 16356667

elsevier.com

linkinghub.elsevier.com

Friedel A, Geyer H, Kamber M, et al. (June 2006), “Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucocorticoid signalling in the liver”, Toxicol. Lett. 164 (1): 16-23, doi:10.1016/j.toxlet.2005.11.006, PMID 16356667

endocrinology-journals.org

joe.endocrinology-journals.org

Labrie F, Luu-The V, Calvo E, et al. (February 2005), “Tetrahydrogestrinone induces a genomic signature typical of a potent anabolic steroid”, J. Endocrinol. 184 (2): 427-33, doi:10.1677/joe.1.05997, PMID 15684350

endojournals.org

jcem.endojournals.org

Death AK, McGrath KC, Kazlauskas R, Handelsman DJ (May 2004), “Tetrahydrogestrinone is a potent androgen and progestin”, J. Clin. Endocrinol. Metab. 89 (5): 2498-500, doi:10.1210/jc.2004-0033, PMID 15126583

endo.endojournals.org

Jasuja R, Catlin DH, Miller A, et al. (October 2005), “Tetrahydrogestrinone is an androgenic steroid that stimulates androgen receptor-mediated, myogenic differentiation in C3H10T1/2 multipotent mesenchymal cells and promotes muscle accretion in orchidectomized male rats”, Endocrinology 146 (10): 4472-8, doi:10.1210/en.2005-0448, PMID 15976054

fda.gov

Oct.2003 FDA statement on THG

nih.gov

pubmed.ncbi.nlm.nih.gov

pubmedcentral.nih.gov

Kicman AT (June 2008), “Pharmacology of anabolic steroids”, Br. J. Pharmacol. 154 (3): 502-21, doi:10.1038/bjp.2008.165, PMC 2439524, PMID 18500378

ncbi.nlm.nih.gov

Kicman AT (June 2008), “Pharmacology of anabolic steroids”, Br. J. Pharmacol. 154 (3): 502-21, doi:10.1038/bjp.2008.165, PMC 2439524, PMID 18500378

usatoday.com

http://www.usatoday.com/sports/olympics/2007-02-28-catlin-drug-lab_N.htm USA Today, 28 February 2007.